Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms-Reference-Cited by-同舟云学术

Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms

Published:2020-08-19 Issue:7831 Volume:586 Page:807-811
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Billesbølle Christian B.^ORCID,Azumaya Caleigh M.,Kretsch Rachael C.,Powers Alexander S.,Gonen Shane,Schneider Simon,Arvedson Tara,Dror Ron O.^ORCID,Cheng Yifan^ORCID,Manglik Aashish^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-020-2668-z.pdf

Reference83 articles.

1. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093 (2004).

2. Drakesmith, H., Nemeth, E. & Ganz, T. Ironing out ferroportin. Cell Metab. 22, 777–787 (2015).

3. Donovan, A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191–200 (2005).

4. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781 (2000).

5. Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F. & Wessling-Resnick, M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl Acad. Sci. USA 102, 1324–1328 (2005).

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A two-pronged approach to inhibit ferroptosis of MSCs caused by the iron overload in postmenopausal osteoporosis and promote osseointegration of titanium implant;Bioactive Materials;2024-11

2. E3 ubiquitin ligases SMURF1 and HECW1 regulate hepcidin-induced degradation of ferroportin in HeLa cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype;Human Genetics and Genomics Advances;2024-10

4. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations;International Journal of Biological Macromolecules;2024-10

5. The role of iron transporters and regulators in Alzheimer’s disease and Parkinson’s disease: Pathophysiological insights and therapeutic prospects;Biomedicine & Pharmacotherapy;2024-10